SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen PreparednessKizzmekia S. Corbett, Tracy J. Ruckwardt, Christine A. Shaw et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 143